PyInvesting

Market research

000952.SHE Hubei Guangji Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

5.56 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
2B
P/E ratio
Not available
Analyst target
40
Dividend yield
Not available
Beta
0.26

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Hubei Guangji Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 1.3% below its 200 day moving average.

From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.6.

Hubei Guangji Pharmaceutical Co., Ltd's total revenue sank by 0.4% to $175M since the same quarter in the previous year.

Its net income has increased by 255.5% to $27M since the same quarter in the previous year.

Finally, its free cash flow grew by 99.2% to $-207K since the same quarter in the previous year.

Based on the above factors, Hubei Guangji Pharmaceutical Co., Ltd gets an overall score of 3/5.